Home » Topics » Regulatory » Patents

Patents
RSS

GH secretagogues under development at Merck

Dec. 23, 1997

Lilly research leads to the discovery of new antiobesity compounds

Dec. 23, 1997

Anandamide amidase inhibitors reported in patent literature

Dec. 23, 1997

Neurokinin antagonists in the pipeline at Schering-Plough

Dec. 23, 1997

Dopamine synthesis and release inhibitors discovered at AHP

Dec. 23, 1997

New prodrug approach claimed by Merck & Co.

Dec. 23, 1997

New antiviral agent for flu disclosed in patent literature

Dec. 22, 1997

HGS discloses new cysteine protease inhibitor

Dec. 22, 1997

Peptidomimetic inhibitors of protein farnesyltransferase from Merck & Co.

Dec. 22, 1997

Farnesyltransferase inhibitors lacking a thiol moiety from Merck & Co.

Dec. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026